Tahir Siddique, et al. “Efficacy and Safety of Once-Weekly Semaglutide Versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial”. Journal of Health, Wellness and Community Research, vol. 3, no. 1, Mar. 2025, pp. 1-8, https://doi.org/10.61919/qxt0b644.